Innovations and State of the Art In Dementia Research

7-9 Sep 2017, Rome, Italy

Innovinc invites you to participate in the “Innovations and State of the Art In Dementia Research” will takes place on Sep 07 - 09, 2017, Rome, Italy

S7

Subbu 760

Program Manager

Prof. George Perry

Speaker

George Perry (born April 12, 1953 In Lompoc, California) Is A neuroscientist Recognized In The Field Of Alzheimer's Disease Research Particularly For His Work In oxidative Stress. Dr. Perry Has Studied At Many Universities And Holds Multiple Degrees Including A Bachelor Of Arts Degree In Zoology From The University Of California Santa Barbara And A PhD In Marine Biology From The Scripps Institution Of Oceanography At San Diego. He Is Distinguished As One Of The Top Alzheimer’s Disease Researchers By Expertscape With Over 1000 Publications, More Than 66,000 Citations (H=129), One Of The Top 100 Most-cited Scientists In Neuroscience & Behavior And One Of The Top 25 Scientists In Free Radical Research. Dr. Perry Is A Semmes Foundation Distinguished University Chair In Neurobiology And Is An Active Participant In Many Other Scientific Associations.  He Is An Elected Member Of The Academies Of Sciences Of Mexico, Portugal, And Spain. In Addition, Perry Is An Editor Of Numerous Scientific Journals Including Journal Of Alzheimer’s Disease which He Founded In 1998. Today, Perry Continues His Love For Research While Working As Dean Of The College Of Sciences At The University Of Texas At San Antonio. 

Othman Ghribi

Othman Ghribi

Speaker

Othman Ghribi Has Completed His Ph.D In Neuropharmacology In 1994 At The University René Descartes, Paris France, And Postdoctoral Studies From The University Of Quebec (1996-1999). Dr Ghribi Then Joined The Department Of Pathology At The University Of Virginia (1999-2004) And The Department Of Biomedical Sciences At The University Of North Dakota School Of Medicine In 2004.  He Has Published More Than 70 Papers In Reputed Journals And Is Serving On The Editorial Board Of The Journal Of Alzheimer’s Disease, Current Alzheimer’s Disease, And The Journal Of Neurodegenerative Diseases. Dr. Ghribi’s Current Research Is Funded By The National Institute Of Health And Focuses On The Role Of The Interactions Between Environmental Factors (chemical And Dietary) And Genetic Susceptibility In The Pathophysiology Of Alzheimer’s And Parkinson’s Diseases. He Specifically Focuses On The Potential Role Of Endoplasmic Reticulum Stress And Lipid Dyshomeostasis In Inducing Neurodegeneration.

This website uses cookies. By continuing to browse you agree to this and Conferize's terms of service.